M Di Nisio Selected Research

Catheters

9/2007

Prevention of catheter-related venous thrombosis with nadroparin in patients receiving chemotherapy for hematologic malignancies: a randomized, placebo-controlled study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

M Di Nisio Research Topics

Disease

11	Neoplasms (Cancer) 01/2020 - 06/2005
8	Venous Thromboembolism 01/2020 - 02/2007
5	Hemorrhage 01/2020 - 09/2007
5	Pulmonary Embolism 01/2017 - 06/2005
3	Venous Thrombosis (Deep-Vein Thrombosis) 09/2007 - 01/2006
2	Thrombophilia 05/2021 - 04/2005
2	Hematologic Neoplasms (Hematological Malignancy) 01/2020 - 09/2007
2	Thrombosis (Thrombus) 11/2013 - 02/2013
2	Disseminated Intravascular Coagulation 11/2013 - 02/2013
1	Obesity 05/2021
1	Breast Neoplasms (Breast Cancer) 01/2020
1	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 01/2020
1	Lung Neoplasms (Lung Cancer) 01/2020
1	Urogenital Neoplasms 01/2020
1	Upper Extremity Deep Vein Thrombosis 01/2017
1	Wounds and Injuries (Trauma) 02/2013
1	Critical Illness (Critically Ill) 02/2013
1	Leukemia 02/2013
1	Thrombocytopenia (Thrombopenia) 03/2012
1	Cardiovascular Diseases (Cardiovascular Disease) 03/2012
1	Acute Coronary Syndrome 03/2012
1	ST Elevation Myocardial Infarction 03/2012
1	Catheter-Related Infections 09/2007
1	Spontaneous Abortion (Miscarriage) 04/2005
1	Fetal Death 04/2005
1	Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome) 04/2005

Drug/Important Bio-Agent (IBA)

7	AnticoagulantsIBA 10/2018 - 04/2005
6	fibrin fragment D (D-dimer)IBA 01/2017 - 06/2005
4	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 11/2014 - 07/2005
2	edoxabanIBA 01/2020 - 01/2020
2	Vitamin K FDA Link 11/2014 - 11/2013
2	Heparin (Liquaemin)FDA LinkGeneric 02/2013 - 04/2005
1	Protein CIBA 05/2021
1	Factor VIII (Coagulation Factor VIII)IBA 05/2021
1	Dalteparin (Dalteparin Sodium)FDA Link 01/2020
1	von Willebrand FactorIBA 02/2016
1	Antifibrinolytic Agents (Antifibrinolytics)IBA 02/2013
1	Dacarbazine (DIC)FDA LinkGeneric 02/2013
1	Fondaparinux (Arixtra)FDA Link 11/2012
1	Eptifibatide (Integrilin)FDA Link 03/2012
1	Tirofiban (Aggrastat)FDA Link 03/2012
1	omega-Chloroacetophenone (Mace)IBA 03/2012
1	Pharmaceutical PreparationsIBA 03/2012
1	Abciximab (ReoPro)FDA Link 03/2012
1	Nadroparin (Nadroparin Calcium)IBA 09/2007
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 04/2005
1	Anticardiolipin AntibodiesIBA 04/2005

Therapy/Procedure

3	Therapeutics 01/2020 - 11/2013
1	Neoadjuvant Therapy 01/2018
1	Duration of Therapy 11/2014
1	Percutaneous Coronary Intervention 03/2012
1	Drug Therapy (Chemotherapy) 09/2007
1	Catheters 09/2007
1	Stem Cell Transplantation 09/2007